Niemann-Pick disease is characterized by a deficiency in which enzyme?

Niemann-Pick disease is characterized by a deficiency in which enzyme?

• A. Galactocerebrosidase
• B. Sphingomyelinase
• C. Acyl-CoA synthetase
• D. Glucocerebrosidase

Answer: (B)

Niemann-Pick disease is a type of sphingolipidosis caused by a deficiency in the enzyme sphingomyelinase. This enzyme plays a crucial role in the metabolism of sphingomyelin, a type of sphingolipid that is found in cell membranes, particularly in the brain, liver, and spleen. In Niemann-Pick disease, the lack of sphingomyelinase leads to the accumulation of sphingomyelin within lysosomes, resulting in cellular damage and the various clinical manifestations associated with the disease, such as hepatosplenomegaly, neurodegeneration, and skin involvement, depending on the specific subtype. Understanding the role of sphingomyelinase is critical in recognizing the biochemical pathway affected by Niemann-Pick disease, which distinguishes it from other lysosomal storage disorders that are characterized by deficiencies in different enzymes. For example, deficiencies in galactocerebrosidase cause Krabbe disease, and glucocerebrosidase deficiency is associated with Gaucher disease, highlighting the specificity of each condition to its corresponding enzyme deficiency. In summary, the specificity of sphingomyelinase deficiency in Niemann-Pick disease underscores its distinct pathophysiology and clinical presentation.

Niemann-Pick disease is a type of sphingolipidosis caused by a deficiency in the enzyme sphingomyelinase. This enzyme plays a crucial role in the metabolism of sphingomyelin, a type of sphingolipid that is found in cell membranes, particularly in the brain, liver, and spleen. In Niemann-Pick disease, the lack of sphingomyelinase leads to the accumulation of sphingomyelin within lysosomes, resulting in cellular damage and the various clinical manifestations associated with the disease, such as hepatosplenomegaly, neurodegeneration, and skin involvement, depending on the specific subtype.

Understanding the role of sphingomyelinase is critical in recognizing the biochemical pathway affected by Niemann-Pick disease, which distinguishes it from other lysosomal storage disorders that are characterized by deficiencies in different enzymes. For example, deficiencies in galactocerebrosidase cause Krabbe disease, and glucocerebrosidase deficiency is associated with Gaucher disease, highlighting the specificity of each condition to its corresponding enzyme deficiency.

In summary, the specificity of sphingomyelinase deficiency in Niemann-Pick disease underscores its distinct pathophysiology and clinical presentation.